Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

IsraelRecruitingPHASE1, PHASE2

Conditions

Age-Related Macular Degeneration · Geographic Atrophy · Non-neovascular AMD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Retina Macula Institute of AZ, Scottsdale, Arizona, United States

  • The Retina Partners, Encino, California, United States

  • Retinal Consultants Medical Group, Sacramento, California, United States

  • Retina Consultants San Diego, San Diego, California, United States

  • Star Retina, Burleson, Texas, United States

  • Retina Center of Texas, Southlake, Texas, United States

  • University of Utah John A. Moran Eye Center, Salt Lake City, Utah, United States

  • Sydney Retina Clinic and Day Surgery, Sydney, New South Wales, Australia

  • Cerulea Clinical Trials, East Melbourne, Victoria, Australia

  • Rambam Medical Center, Haifa, Israel

  • Tel-Aviv Sourasky Medical Center, Ophthalmology Division, Tel Aviv, Israel

Study leads
  • Anne Fung, MD

    Study Director

    Perceive Biotherapeutics, Inc.